NYSE: ABC | Healthcare / Medical Distribution / USA |
179.98 | -0.4100 | -0.23% | Vol 804.15K | 1Y Perf 22.31% |
Aug 29th, 2023 16:00 DELAYED |
BID | 175.00 | ASK | 180.61 | ||
Open | 180.93 | Previous Close | 179.98 | ||
Pre-Market | - | After-Market | - | ||
- - | - -% |
Target Price | 174.91 | Analyst Rating | — — 0.00 | |
Potential % | - | Finscreener Ranking | ☆ — - | |
Insiders Trans % 3/6/12 mo. | -100/-100/-100 | Value Ranking | ☆ — - | |
Insiders Value % 3/6/12 mo. | -100/-100/-100 | Growth Ranking | + — - | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-100 | Income Ranking | + — - | |
Price Range Ratio 52W % | 0.00 | Earnings Rating | Buy | |
Market Cap | 36.39B | Earnings Date | 2nd Aug 2023 | |
Alpha | 0.01 | Standard Deviation | 0.06 | |
Beta | 0.56 |
Today's Price Range 179.24180.93 | 52W Range 135.14194.79 | 5 Year PE Ratio Range -5.5064.80 |
Summary:
Neutral
Technical Indicators: | Neutral |
Moving Averages: | Neutral |
Performance | |||
---|---|---|---|
1 Week | - | ||
1 Month | - | ||
3 Months | 0.00% | ||
6 Months | 3.13% | ||
1 Year | 22.31% | ||
3 Years | 74.53% | ||
5 Years | 102.45% | ||
10 Years | 160.33% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | -11.16 | |||
ROE last 12 Months | -15 204.00 | |||
ROA (5Y Avg) | -0.34 | |||
ROA last 12 Months | 3.23 | |||
ROC (5Y Avg) | -1.80 | |||
ROC last 12 Months | 29.87 | |||
Return on invested Capital Q | 5.69 | |||
Return on invested Capital Y | 29.33 | |||
Assets Turnover | 3.60 | |||
Receivables Turnover | 10.90 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
20.60 | ||||
471.12 | ||||
0.19 | ||||
12.90 | ||||
25.50 | ||||
12.80 | ||||
-2.57 | ||||
-1.05 | ||||
35.80B | ||||
Forward PE | 14.04 | |||
PEG | 2.45 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.50 | ||||
0.90 | ||||
0.98 | ||||
80.01 | ||||
10.40 | ||||
Leverage Ratio | 389.20 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
3.50 | ||||
1.10 | ||||
1.40 | ||||
0.00 | ||||
0.68 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
178.96B | ||||
885.59 | ||||
7.04 | ||||
7.84 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
1.18 | ||||
1.94 | ||||
4.57 | ||||
4.46 | ||||
Payout ratio | 21.00 |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q03 2023 | 2.83 | 2.92 | 3.18 |
Q02 2023 | 3.29 | 3.50 | 6.38 |
Q01 2023 | 2.62 | 2.71 | 3.44 |
Q04 2022 | 2.58 | 2.60 | 0.78 |
Q03 2022 | 2.57 | 2.62 | 1.95 |
Q02 2022 | 2.99 | 3.22 | 7.69 |
Q01 2022 | 2.59 | 2.58 | -0.39 |
Q04 2021 | 2.36 | 2.39 | 1.27 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
9/2023 QR | 2.79 | -1.06 | Negative |
9/2023 FY | 11.92 | 0.34 | Positive |
12/2023 QR | 2.78 | -1.07 | Negative |
9/2024 FY | 12.81 | 1.99 | Positive |
Next Report Date | - |
Estimated EPS Next Report | 2.83 |
Estimates Count | 6 |
EPS Growth Next 5 Years % | - |
Volume Overview | |
---|---|
Volume | 804.15K |
Shares Outstanding | 202.17K |
Shares Float | 118.13M |
Trades Count | 18.36K |
Dollar Volume | 144.71M |
Avg. Volume | 1.53M |
Avg. Weekly Volume | 1.12M |
Avg. Monthly Volume | 2.00M |
Avg. Quarterly Volume | 1.47M |
AmerisourceBergen Corporation (NYSE: ABC) stock closed at 179.98 per share at the end of the most recent trading day (a -0.23% change compared to the prior day closing price) with a volume of 804.15K shares and market capitalization of 36.39B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Distribution industry, Healthcare sector and employs 22000 people. AmerisourceBergen Corporation CEO is Steven H. Collis.
The one-year performance of AmerisourceBergen Corporation stock is 22.31%, while year-to-date (YTD) performance is 8.61%. ABC stock has a five-year performance of 102.45%. Its 52-week range is between 135.14 and 194.79, which gives ABC stock a 52-week price range ratio of %
AmerisourceBergen Corporation currently has a PE ratio of 20.60, a price-to-book (PB) ratio of 471.12, a price-to-sale (PS) ratio of 0.19, a price to cashflow ratio of 12.90, a PEG ratio of 2.45, a ROA of 3.23%, a ROC of 29.87% and a ROE of -15 204.00%. The company’s profit margin is 0.68%, its EBITDA margin is 1.40%, and its revenue ttm is $178.96 Billion , which makes it $885.59 revenue per share.
Of the last four earnings reports from AmerisourceBergen Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.83 for the next earnings report. AmerisourceBergen Corporation’s next earnings report date is -.
The consensus rating of Wall Street analysts for AmerisourceBergen Corporation is — (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for AmerisourceBergen Corporation stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
AmerisourceBergen Corporation has a dividend yield of 1.18% with a dividend per share of $1.94 and a payout ratio of 21.00%.
AmerisourceBergen Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 8.18, ATR14 : 2.54, CCI20 : -68.48, Chaikin Money Flow : -0.22, MACD : -2.34, Money Flow Index : 55.07, ROC : -3.94, RSI : 38.69, STOCH (14,3) : 24.23, STOCH RSI : 0.90, UO : 40.11, Williams %R : -75.77), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of AmerisourceBergen Corporation in the last 12-months were: Battaglia Silvana (Sold 0 shares of value $0 ), Boots Alliance, Inc. Walgreens (Sold 568 776 shares of value $100 000 108 ), Clark Gina (Option Excercise at a value of $2 135 331), Clark Gina (Sold 29 466 shares of value $5 446 787 ), Cleary James (Option Excercise at a value of $2 901 609), Collis Steven (Option Excercise at a value of $4 883 925), Collis Steven (Sold 62 994 shares of value $10 382 038 ), Dennis M. Nally (Option Excercise at a value of $0), Dermot Mark Durcan (Option Excercise at a value of $0), Donato Leslie E (Option Exercise at a value of $0), Elizabeth S. Campbell (Option Excercise at a value of $256 237), Elizabeth S. Campbell (Sold 7 500 shares of value $1 305 884 ), Gina K. Clark (Option Excercise at a value of $0), Gina K. Clark (Sold 2 316 shares of value $365 755 ), Henry W. McGee (Option Excercise at a value of $0), Hyle Kathleen (Option Excercise at a value of $0), James F. Cleary (Option Excercise at a value of $0), Jane E Henney (Option Excercise at a value of $0), Jane E. Henney (Option Excercise at a value of $0), Kathleen W. Hyle (Option Excercise at a value of $0), Lazarus Krikorian (Option Excercise at a value of $198 688), Lazarus Krikorian (Sold 7 929 shares of value $1 265 262 ), Leslie E. Donato (Sold 3 944 shares of value $658 786 ), Lon R. Greenberg (Sold 0 shares of value $0 ), Michael J. Long (Option Excercise at a value of $0), Richard W. Gochnauer (Option Excercise at a value of $0), Robert P. Mauch (Option Excercise at a value of $0), Silvana Battaglia (Option Excercise at a value of $777 479), Silvana Battaglia (Sold 9 852 shares of value $1 645 284 ), Steven H. Collis (Option Excercise at a value of $6 727 961), Steven H. Collis (Sold 120 916 shares of value $19 812 502 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | - | - | - |
AmerisourceBergen is a leading pharmaceutical wholesaler engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospital networks, and healthcare providers. Along with McKesson and Cardinal Health, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Through bolt-on acquisitions, the company has expanded into international wholesale in Europe (Alliance Healthcare) and South America (Profarma). AmerisourceBergen provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health).
CEO: Steven H. Collis
Telephone: +1 610 727-7000
Address: 1300 Morris Drive, Chesterbrook 19087-5594, PA, US
Number of employees: 22 000
Wed, 30 Aug 2023 11:37 GMT Cencora completes name change from AmerisourceBergen
- TipRanks. All rights reserved.Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.
General partner of Finscreener is SLOVAKODATA, a.s.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.